Medical cannabis in the management of musculoskeletal pain: a systematic review of clinical trials

1. Ritchie CS, Patel K, Boscardin J, Miaskowski C, Vranceanu AM, Whitlock E, Smith A. Impact of persistent pain on function, cognition, and well-being of older adults. J Am Geriatr Soc. 2023; 71 (1): 26–35.

2. Mills SEE, Nicolson KP, Smith BH. Chronic pain: a review of its epidemiology and associated factors in population-based studies. Br J Anaesth. 2019; 123 (2): e273–e283.

3. de Barros GAM, Pos AM, Sousa ÂM, Pereira CL, Nobre CDA, Palmeira CCA, et al. Cannabinoid products for pain management: recommendations from the São Paulo State Society of Anesthesiology. Braz J Anesthesiol. 2024; 74 (4): 844513.

4. Boehnke KF, Häuser W, Fitzcharles MA. Cannabidiol (CBD) in Rheumatic Diseases (Musculoskeletal Pain). Curr Rheumatol Rep. 2022; 24 (7): 238–246.

5. Stella B, Baratta F, Della Pepa C, Arpicco S, Gastaldi D, Dosio F. Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain. Drugs. 2021; 81 (13): 1513–1557.

6. Matarazzo AP, Elisei LMS, Carvalho FC, Bonfilio R, Ruela ALM, Galdino G, et al. Mucoadhesive nanostructured lipid carriers as a cannabidiol nasal delivery system for the treatment of neuropathic pain. Eur J Pharm Sci. 2021; 159: 105698.

7. Ang SP, Sidharthan S, Lai W, Hussain N, Patel KV, Gulati A, et al. Cannabinoids as a Potential Alternative to Opioids in the Management of Various Pain Subtypes: Benefits, Limitations, and Risks. Pain Ther. 2023; 12 (2): 355–375.

8. Stefano GB, Quinn E, Kream RM. Endocannabinoid Stimulated Release of Nitric Oxide and its Mito- chondrial Influence Triggering Vascular Pathology. Pharm Anal Acta. 2015; 6 (6): 378.

9. Maida V, Shi RB, Fazzari FGT, Zomparelli L. Topical cannabis-based medicines - A novel paradigm and treatment for non-uremic calciphylaxis leg ulcers: An open label trial. Int Wound J. 2020; 17 (5): 1508–1516.

10. Mallick-Searle T, St Marie B. Cannabinoids in Pain Treatment: An Overview. Pain Manag Nurs. 2019; 20 (2): 107–112.

11. Bell AD, MacCallum C, Margolese S, Walsh Z, Wright P, Daeninck PJ, et al. Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions. Cannabis Cannabinoid Res. 2024; 9 (2): 669–687.

12. Maayah ZH, Takahara S, Ferdaoussi M, Dyck JRB. The molecular mechanisms that underpin the biological benefits of full-spectrum cannabis extract in the treatment of neuropathic pain and inflammation. Biochim Biophys Acta Mol Basis Dis. 2020; 1866 (7): 165771.

13. Rodriguez CEB, Ouyang L, Kandasamy R. Antinociceptive effects of minor cannabinoids, terpenes and flavonoids in Cannabis. Behav Pharmacol. 2022; 33 (2&3): 130–157.

14. Safi K, Sobieraj J, Błaszkiewicz M, Żyła J, Salata B, Dzierżanowski T. Tetrahydrocannabinol and Cannabidiol for Pain Treatment-An Update on the Evidence. Biomedicines. 2024; 29; 12 (2): 307.

15. Burdinski DCL, Kodibagkar A, Potter K, Schuster RM, Evins AE, Ghosh SS, et al. Year-Long Cannabis Use for Medical Symptoms and Brain Activation During Cognitive Processes. JAMA Netw Open. 2024; 7 (9): e2434354.

16. Boehnke KF, Yakas L, Scott JR, DeJonckheere M, Litinas E, Sisley S, et al. A mixed methods analysis of cannabis use routines for chronic pain management. J Cannabis Res. 2022; 4 (1): 7.

17. Francis A, Erridge S, Holvey C, Coomber R, Holden W, Rucker J, et al. Assessment of Clinical Outcomes in Patients With Osteoarthritis: Analysis From the UK Medical Cannabis Registry. J Pain Palliat Care Pharmacother. 2024; 38 (2): 103–116.

18. USA Arthritis Foundation – blog.arthritis.org. Patients Tell Us About CBD Use. [updated 8th August 2019]. Available from: https://www.arthritis.org/news/patients-tell-us-cbd-use. Accessed 02/07/2024.

19. Aggarwal SK, Carter GT, Sullivan MD, ZumBrunnen C, Morrill R, Mayer JD. Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State. J Opioid Manag. 2009; 5 (5): 257–286.

20. Harris D, Jones RT, Shank R, Nath R, Fernandez E, Goldstein K, Mendelson J. Self-reported marijuana effects and characteristics of 100 San Francisco medical marijuana club members. J Addict Dis. 2000; 19 (3): 89–103.

21. Furrer D, Kröger E, Marcotte M, Jauvin N, Bélanger R, Ware M, et al. Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions. J Cannabis Res. 2021; 3 (1): 41.

22. Swift W, Gates P, Dillon P. Survey of Australians using cannabis for medical purposes. Harm Reduct J. 2005; 4; 2: 18.

23. Narayanan V, Gandhi R, Suryavanshi A, Nadkarni B, Rungta V. Topical cannabinoids for the management of musculoskeletal pain: Understanding and review. Int J Ortop Res. 2022; 83–88.

24. Polish Drug base: https://www.mp.pl/pacjent/ leki/lek/88409,Sativex-aerozol-do-stosowania-w-jamie-ustnej. Accessed 02/08/2024.

25. Potts AJ, Cano C, Thomas SHL, Hill SL. Synthetic cannabinoid receptor agonists: classification and nomenclature. Clin Toxicol (Phila). 2020; 58 (2): 82–98.

26. Poisblaud L, Kröger E, Jauvin N, Pelletier-Jacob J, Bélanger RE, et al. Perceptions and Preoccupations of Patients and Physicians Regarding Use of Medical Cannabis as an Intervention Against Chronic Musculoskeletal Pain: Results from a Qualitative Study. J Pain Res. 2023; 16: 3463–3475.

27. Matos AP, Pegorari MS. How to Classify Clinical Trials Using the PEDro Scale? J Lasers Med Sci. 2020; 11 (1): 1–2.

28. Heineman JT, Forster GL, Stephens KL, Cottler PS, Timko MP, DeGeorge BR Jr. A Randomized Controlled Trial of Topical Cannabidiol for the Treatment of Thumb Basal Joint Arthritis. J H Hand Surg Am. 2022; 47 (7): 611–620.

29. Nitecka-Buchta A, Nowak-Wachol A, Wachol K, Walczyńska-Dragon K, Olczyk P, Batoryna O, Kempa W, Baron S. Myorelaxant Effect of Transdermal Cannabidiol Application in Patients with TMD: A Randomized, Double-Blind Trial. J Clin Med. 2019; 8 (11): 1886.

30. Hunter D, Oldfield G, Tich N, Messenheimer J, Sebree T. Synthetic transdermal cannabidiol for the treatment of knee pain due to osteoarthritis. Osteoarthr Cartil. 2018; 26 (1): S26.

31. Capano A, Weaver R, Burkman E. Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study. Postgrad Med. 2020; 132 (1): 56–61.

32. Vigil JM, Stith SS, Adams IM, Reeve AP. Associations between medical cannabis and prescription opioid use in chronic pain patients: A preliminary cohort study. PLoS One. 2017: 16; 12 (11): e0187795.

33. Bawa Z, Lewis D, Gavin PD, Libinaki R, Joubran L, El-Tamimy M, Taylor G, Meltzer R, Bedoya-Pérez M, Kevin RC, McGregor IS. An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis. Sci Rep. 2024: 23; 14 (1): 11792.

34. Haroutounian S, Ratz Y, Ginosar Y, Furmanov K, Saifi F, Meidan R, Davidson E. The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-label Study. Clin J Pain. 2016; 32 (12): 1036–1043.

35. O’Brien K, Beilby J, Frans M, et al. Medicinal cannabis for pain: Real-world data on three-month changes in symptoms and quality of life. Drug Science, Policy and Law 2023; (9): 1–12.

36. Mangual-Pérez D, Tresgallo-Parés R, RamírezGonzález M, Torres-Lugo NJ, Rivera-Dones A, Rivera-Rodríguez G, Claudio-Marcano A, Lojo-Sojo L. Patient Experience and Perspective on Medical Cannabis as an Alternative for Musculoskeletal Pain Management. J Am Acad Orthop Surg Glob Res Rev. 2022; 6 (7): e22.00055.

37. Holt A, Nouhravesh N, Strange JE, Kinnberg Nielsen S, Schjerning AM, et al. Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study. Eur Heart J. 2024; 45 (6): 475–484.

38. Safakish R, Ko G, Salimpour V, Hendin B, Sohanpal I, Loheswaran G, Yoon SYR. Medical Cannabis for the Management of Pain and Quality of Life in Chronic Pain Patients: A Prospective Observational Study. Pain Med. 2020; 21 (11): 3073–3086.

39. Bellnier T, Brown GW, Ortega TR. Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis. Ment Health Clin. 2018; 8 (3): 110–115.

40. Klimkiewicz A. (ed.). Konopie i medyczne zastosowanie kannabinoidów – praktyczne rekomendacje [Cannabis and the medical use of cannabinoids - practical recommendations]. Ewdomed 2022.

41. Johal H, Vannabouathong C, Chang Y, Zhu M, Bhandari M. Medical cannabis for orthopaedic patients with chronic musculoskeletal pain: does evidence support its use? Ther Adv Musculoskelet Dis. 2020; 12: 1759720X20937968.

42. O'Connor CM, Anoushiravani AA, Adams C, Young JR, Richardson K, Rosenbaum AJ. Cannabinoid Use in Musculoskeletal Illness: A Review of the Current Evidence. Curr Rev Musculoskelet Med. 2020; 13 (4): 379–384.

43. Food Public Warning by National Sanitary Inspectorate about hemp olis: https://www.gov.pl/web/gis/ ostrzezenie-publiczne-dotyczace-zywnosci-stwierdzenie-niedozwolonego-ekstraktu-z-konopi-wloknistych-oraz-zawartosc-9-tetrahydrokannabinol-9-thc-na-poziomie-09-gkg-12-gkg-15-gkgw-produktach-pn-premium-quality-hemp-oil-olejek-konopny-10-5-ml-i-10-ml-oraz-premium-quality-hemp-oil-dietary-supplement-olejek-konopny5cbd-5-ml-i-10-ml. Accessed 02/09/2024.

44. Ochmańska K.Pietrosiuk A. The importance of cannabinoids in modern medicine. Lek Pol. 2022: 12; 33–38. [Article in Polish].

45. Frane N, Stapleton E, Iturriaga C, Ganz M, Rasquinha V, Duarte R. Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study. J Cannabis Res. 2022; 4 (1): 47.

46. Senderovich H, Wagman H, Zhang D, Vinoraj D, Waicus S. The Effectiveness of Cannabis and Cannabis Derivatives in Treating Lower Back Pain in the Aged Population: A Systematic Review. Gerontology. 2022; 68 (6): 612–624.

47. Madden K, van der Hoek N, Chona S, George A, Dalchand T, Baldawi H, et al. Cannabinoids in the Management of Musculoskeletal Pain: A Critical Review of the Evidence. JBJS Rev. 2018; 6 (5): e7.

48. Fitzcharles MA, Ste-Marie PA, Häuser W, Clauw DJ, Jamal S, Karsh J, et al. Efficacy, Tolerability, and Safety of Cannabinoid Treatments in the Rheumatic Diseases: A Systematic Review of Randomized Controlled Trials. Arthritis Care Res (Hoboken). 2016; 68 (5): 681–6818.